FAWAZ JAN SYRIL GEORGIE

Allopathic & Osteopathic Physicians|Internal Medicine|Cardiovascular Disease FARMINGTON HILLS, MI NPI 1932561982

General Payments — all program years on this page

$4,289.49

  • Category: General Payments
  • Program years: PY2019–2024
  • Record count: 74
  • As of (CMS publication): 2026-01-23

Latest program year (PY2024): $722.05 across 20 records · disputed records: 0

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How this figure is calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

Latest program year (PY2024) · sorted by reported total.

Nature of paymentAmountRecords
Food and Beverage $722.0520

By paying entity

Latest program year (PY2024) · sorted by reported total.

By program year

Program yearAmountRecords
2019 $104.981
2020 $383.064
2021 $683.787
2022 $1,244.4416
2023 $1,151.1826
2024 $722.0520

Records — PY2024 (20)

Record IDPaying entityAmountDate Nature of paymentDispute statusPublishedSource
1078895075 Actelion Pharmaceuticals US, Inc. $22.60 01/29/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1080602123 ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) $18.60 02/16/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1080602130 ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) $83.33 06/05/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1081709683 Lexicon Pharmaceuticals, Inc. $148.47 05/23/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1086804283 Novartis Pharmaceuticals Corporation $23.53 11/18/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1104761660 AstraZeneca Pharmaceuticals LP $28.75 05/15/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1105744830 AstraZeneca Pharmaceuticals LP $14.46 07/08/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1111582374 Amgen Inc. $145.65 10/29/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1118241658 Boehringer Ingelheim Pharmaceuticals, Inc. $20.78 02/12/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1125346189 Abbott Laboratories $16.01 01/03/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1125346191 Abbott Laboratories $23.11 09/14/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1125346193 Abbott Laboratories $17.52 12/26/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1131199208 PFIZER INC. $19.85 11/05/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1131460698 PFIZER INC. $14.78 05/16/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1131744358 PFIZER INC. $21.59 07/01/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1131823782 PFIZER INC. $15.77 07/23/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1131977989 PFIZER INC. $16.98 09/09/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1132035010 PFIZER INC. $16.63 07/25/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1142259836 ABIOMED $29.91 09/13/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1152379886 Kestra Medical Technology Services, Inc. $23.73 10/10/2024 Food and Beverage Undisputed 01/23/2026 View at CMS

Provenance & corrections

  • Dataset: CMS Open Payments — General Payments
  • Source: CMS Open Payments dataset (bulk file)
  • Publisher of source data: Centers for Medicare & Medicaid Services
  • Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.